Biotech Values

[TwoNE1]

What is your view on Cytosorbents Corporation (CTSO)?
Their product, CytoSorb®, is an extracorporeal cytokine adsorber designed to reduce the "cytokine storm" or "cytokine release syndrome".
It is approved in the European Union and widely used in Germany.

This is from their latest press release:

Over the past two weeks, multiple patients with at least respiratory failure, shock, or kidney failure, in multiple hospitals in Wuhan, China have been treated with CytoSorb. Based on preliminary positive feedback on patient outcomes, we have responded to a request for additional devices and have now delivered a second shipment of CytoSorb devices to our partner in China, intended for new critically-ill COVID-19 patients.

https://www.prnewswire.com/news-releases/cytosorbents-provides-update-on-cytosorb-and-covid-19-coronavirus-activities-301022338.html?tc=eml_cleartime&fbclid=IwAR2zyZ3RvPwg1mBM96MbV1BSnFaO9NLs0Q6cylzAxROPYvbjqO5bp68064U